Skip to content

Global Advocacy

Advocating at the global level to achieve cardiovascular health for everyone

Priority Areas

Universal Health Coverage (UHC)

Advocating for fiscal policies, including taxes on tobacco, alcohol and sugar-sweetened beverages, to help fund UHC.

Learn more

Air Pollution

Air pollution is a significant risk factor for CVD and as such must urgently be addressed through research, education, and policy change.

Learn more

Rheumatic Heart Disease (RHD)

RHD is a preventable, treatable form of cardiovascular disease that affects over 33 million people around the world, chiefly in low-resource settings.

Learn more

Tobacco

As smoking prevalence continues to climb in the developing world, we are mobilizing the CVD community in the fight against tobacco.

Learn more

Advocating at the UN

World Health Organization

WHF is the only organization representing the CVD community in Official Relations with the WHO, the global authority on public health policy.

Learn more

United Nations

Our advocacy experts work closely with the UN, its agencies, and other international bodies to influence global policies, strategies and funding.

Learn more

Committees and Expert Groups

Advocacy Committee

This Committee is composed of experts representing each WHO Region. It serves to inform and approve science-based policy proposals.

Learn more

Tobacco Expert Group (TEG)

The TEG supports the development of WHF position papers, external statements, and internal policies to advance progress on global tobacco control.

Learn more

Air Pollution Expert Group (APEG)

The APEG guides the work of WHF in the area of air pollution and CVD, identifying areas for further research and prioritizing key advocacy objectives.

Learn more

Global Coalition for Circulatory Health

Uniting for Circulatory Health

The Global Coalition for Circulatory Health brings together international, regional and national stakeholders in circulatory health.

Learn more

WHF Advocacy Strategy 2019-22

Latest News

Advocating for a tobacco-free world at COP10

The World Heart Federation (WHF) proudly represented the global cardiovascular community at the Tenth Session of the Conference of the Parties to the WHO Framework Convention on Tobacco Control (FCTC), held from 05 to 10 February 2024 in Panama City, Panama. Representatives from 142 Parties gathered to tackle a range of issues, from progress on […]

Tobacco

Addressing novel and emerging tobacco products at COP10

This is a statement delivered by the World Heart Federation at the 10th Session of the Conference of the Parties to the WHO FCTC in Panama. Honourable Chair, Distinguished Delegates, The World Heart Federation welcomes the latest reports on newer tobacco and nicotine products. For decades, the tobacco industry has perpetuated the myth that nicotine […]

Tobacco

Addressing global progress in implementation of the WHO FCTC at COP10

This is a statement delivered by the World Heart Federation at the 10th Session of the Conference of the Parties to the WHO FCTC in Panama. Honourable Chair, Distinguished Delegates, The World Heart Federation applauds the Parties for the progress made since 2021. Nevertheless, we note with concern that interference from the tobacco industry remains […]

Tobacco

WHF at the 154th WHO Executive Board

The World Heart Federation was an active presence throughout the 154th Executive Board (EB154) of the World Health Organization in Geneva, Switzerland from 22-27 January 2024. Advocacy Committee Chair Trevor Shilton and the members of the Policy and Advocacy Team participated throughout the week; in addition to meeting with numerous country delegations and fellow advocates […]